Modulation of heat shock proteins by statins
MetadataShow full item record
Heat shock proteins (HSP or stress proteins) are intracellular molecules that participate in physiological cell metabolism and growth, although they are known to be involved in many stress conditions. Statins inhibit the action of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA), which is important in the synthesis of cholesterol and essential isoprenoid intermediates, thereby lowering circulating low-density lipoprotein cholesterol (LDL), a major risk factor for cardiovascular disease (CVD). This review provides new insights into the mechanisms of action of statins in the regulation of HSPs. A better understanding of this involvement can help in development of new and more effective treatment strategies for CVD. © 2018 Elsevier Ltd
Showing items related by title, author, creator and subject.
ReviewMomtazi-Borojeni A.A.; Sabouri-Rad S.; Gotto A.M.; Pirro M.; Banach M.; Awan Z.; Barreto G.E.; Sahebkar A. (Oxford University Press, 2019)
Psoriasis vulgaris with or without arthritis and independent of disease severity or duration is a risk factor for hypercholesterolemia (2020) Santos-Juanes J.; Coto-Segura P.; Fernández-Vega I.; Armesto S.; Martínez-Camblor P. (S. Karger AG, 2015)
Increased lipoprotein(a) in a paediatric patient associated with nephrotic syndrome [Incremento de lipoproteína(a) en paciente pediátrico asociado a síndrome nefrótico] (2020) Menéndez Valladares P.; Arrobas Velilla T.; Bermúdez de la Vega J.A.; Romero Pérez M.D.M.; Fabiani Romero F.; González Rodríguez C. (Elsevier Doyma, 2016)